IAD Index of Academic Documents
  • Home Page
  • About
    • About Izmir Academy Association
    • About IAD Index
    • IAD Team
    • IAD Logos and Links
    • Policies
    • Contact
  • Submit A Journal
  • Submit A Conference
  • Submit Paper/Book
    • Submit a Preprint
    • Submit a Book
  • Contact
  • Cukurova Medical Journal
  • Volume:49 Issue:1
  • COVID-19 and progress in therapeutic approaches: a narrative review

COVID-19 and progress in therapeutic approaches: a narrative review

Authors : Umair Ilyas, Sarmad Sheraz Jadoon, Tanzeel Ahmed, Reem Altaf, Aslam Khan, Ashfaq Ahmad, Yasir Rasool, Syed Muzzammil Masaud, Zakir Khan
Pages : 204-223
Doi:10.17826/cumj.1394329
View : 48 | Download : 122
Publication Date : 2024-03-29
Article Type : Review Paper
Abstract :Coronavirus disease 2019 (COVID-19), scientifically known as severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) has adversely affect the respiratory system of humans and badly crushed the economies of most developed countries. This study aims to investigate the current COVID-19 situation and therapeutic approaches including non-viral vaccines, efficacy, safety, their trials, dosage protocols and mass vaccination established for COVID-19. A comprehensive literature search was conducted using PubMed, Scopus, Google Scholar, and MEDLINE databases. The title of the research articles were reviewed first, followed by the abstracts and finally the complete studies. This review critically focuses on the damaging effects of COVID-19 and its mutations, multiple variants, pharmacological approaches, and mRNA vaccines. COVID-19 is an emerging new variant with a different mutation and altered genomic structure. Different pharmacological and therapeutic approaches (interferon, oligonucleotides, anti-viral drug molecules, antibody peptides) have been made so far to combat COVID-19. Interferons are employed in COVID-19 treatment approaches owing to the role of Type I interferons in COVID-19 pathogenesis. Along with these therapeutic methodologies, companies from all over the world participated in the run to develop a vaccine for COVID-19. Vaccines were developed in less than a year for vaccinating humans on a mass level for the first time in world history. These vaccines target structural components of the virus, such as membrane proteins with a spike protein. This article provides valuable information for researchers regarding COVID-19 and progress in therapeutic approaches. This article will serve as a hallmark for understanding the COVID-19 mutation mechanism and strategies to combat these mutation points.
Keywords : COVID 19, aşı, tedavisi, replikasyonu

ORIGINAL ARTICLE URL
VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.


Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025